HERPLEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Herplex, and when can generic versions of Herplex launch?
Herplex is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in HERPLEX is idoxuridine. There are two drug master file entries for this compound. Additional details are available on the idoxuridine profile page.
Summary for HERPLEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Patent Applications: | 4,773 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HERPLEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HERPLEX
US Patents and Regulatory Information for HERPLEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | HERPLEX | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 013935-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |